IRIS
CERIELLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.073
AS - Asia 6.678
EU - Europa 4.519
SA - Sud America 1.669
AF - Africa 157
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 7
Totale 36.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.756
SG - Singapore 3.363
UA - Ucraina 1.601
BR - Brasile 1.300
CN - Cina 1.201
DE - Germania 780
FI - Finlandia 667
HK - Hong Kong 646
VN - Vietnam 566
RU - Federazione Russa 341
FR - Francia 264
IE - Irlanda 253
SE - Svezia 180
IT - Italia 165
KR - Corea 162
AR - Argentina 159
CA - Canada 149
TR - Turchia 145
IN - India 131
GB - Regno Unito 117
BD - Bangladesh 99
IQ - Iraq 66
CO - Colombia 52
EC - Ecuador 52
ID - Indonesia 52
ZA - Sudafrica 50
MX - Messico 46
PK - Pakistan 42
VE - Venezuela 33
MA - Marocco 25
ES - Italia 22
CR - Costa Rica 21
JM - Giamaica 21
UZ - Uzbekistan 21
PY - Paraguay 20
TN - Tunisia 20
NL - Olanda 19
CL - Cile 18
JP - Giappone 16
MY - Malesia 15
PE - Perù 15
PL - Polonia 15
SA - Arabia Saudita 15
UY - Uruguay 15
BE - Belgio 14
EU - Europa 14
KZ - Kazakistan 14
PH - Filippine 14
AE - Emirati Arabi Uniti 12
IL - Israele 12
IR - Iran 12
KE - Kenya 12
EG - Egitto 11
GT - Guatemala 11
HN - Honduras 11
OM - Oman 11
AT - Austria 10
DZ - Algeria 10
JO - Giordania 10
TT - Trinidad e Tobago 10
TW - Taiwan 10
CH - Svizzera 9
PT - Portogallo 9
NI - Nicaragua 8
PR - Porto Rico 8
BB - Barbados 7
DO - Repubblica Dominicana 6
EE - Estonia 6
RS - Serbia 6
AU - Australia 5
AZ - Azerbaigian 5
BH - Bahrain 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
HU - Ungheria 5
LB - Libano 5
LT - Lituania 5
PA - Panama 5
SV - El Salvador 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
KG - Kirghizistan 4
SC - Seychelles 4
BS - Bahamas 3
BY - Bielorussia 3
GE - Georgia 3
MD - Moldavia 3
NG - Nigeria 3
NP - Nepal 3
PS - Palestinian Territory 3
RO - Romania 3
AM - Armenia 2
BG - Bulgaria 2
BZ - Belize 2
CG - Congo 2
CI - Costa d'Avorio 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
GA - Gabon 2
Totale 36.081
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.301
Fairfield 2.612
Ann Arbor 2.388
Houston 1.881
Ashburn 1.790
Jacksonville 1.189
Seattle 1.006
Singapore 997
Wilmington 929
Cambridge 926
San Jose 697
Hong Kong 637
Council Bluffs 617
Dearborn 555
Beijing 537
Chandler 528
Boardman 299
Princeton 266
Dublin 253
Lauterbourg 234
Ho Chi Minh City 216
Los Angeles 163
Hefei 158
Seoul 152
San Diego 140
Helsinki 131
São Paulo 131
Buffalo 128
Hanoi 126
Dallas 123
Izmir 116
Munich 100
The Dalles 97
New York 75
Santa Clara 63
Ogden 57
Norwalk 50
Redondo Beach 47
Rio de Janeiro 44
Des Moines 42
Ottawa 42
Phoenix 38
North Bergen 35
San Mateo 35
Belo Horizonte 31
Frankfurt am Main 31
Haiphong 31
Toronto 31
Nanjing 30
Brasília 28
Chicago 27
Grafing 27
Baghdad 25
Porto Alegre 25
Nuremberg 24
Brooklyn 23
Johannesburg 22
Kunming 22
Udine 21
Charlotte 20
Orem 20
Quito 19
Atlanta 18
Campinas 18
Da Nang 18
Denver 18
Guangzhou 18
Mumbai 18
Tashkent 18
Dhaka 17
Guayaquil 17
San José 17
Curitiba 16
Nanchang 16
Salvador 16
Bogotá 15
Milan 15
Buenos Aires 14
Kingston 14
Ribeirão Preto 14
Tokyo 14
Warsaw 14
Hải Dương 13
Jinan 13
Las Vegas 13
Mexico City 13
Medellín 12
Newark 12
Andover 11
Can Tho 11
Guarulhos 11
Hull 11
Lahore 11
Montreal 11
Philadelphia 11
Pittsburgh 11
Sorocaba 11
São José do Rio Preto 11
Thái Bình 11
Brussels 10
Totale 24.940
Salva come PNG Salva come JPEG
Nome #
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship 263
Possible role of oxidative stress in the pathogenesis of hypertension. 234
Oxidative stress and diabetes-associated complications. 217
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat 213
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. 199
The oxygen-release capacity of red blood cells in insulin-dependent diabetics after artificial pancreas. 193
Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. 192
Intra-arterial iloprost for limb ischaemia. 191
The metabolic syndrome--a postprandial disease? 189
Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. 189
Increased prothrombin fragment 1 + 2 in type I diabetic patients. 188
Antioxidant therapy in diabetic complications: what is new? 180
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor 179
Acute hyperglycaemia and oxidative stress generation. 177
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. 176
Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. 175
Total radical-trapping antioxidant parameter in NIDDM patients. 174
Does a common mechanism induce diverse complications of diabetes? 173
D-lysine and non-enzymatic glycation. 172
Pregnancy as environmental factor precipitating IDDM. 171
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. 170
Antioxidant anti-inflammatory treatment in type 2 diabetes. 169
Aspirin and non-enzymatic glycation. 168
Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report. 168
Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human Umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production 168
High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. 167
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. 167
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation 166
Mean red blood cell volume, narcotic addiction, and glucose tolerance 166
Meal-generated oxidative stress in type 2 diabetic patients 165
Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjects. 165
Congestive heart failure and cognitive impairment in the elderly. 165
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. 164
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? 164
Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. 163
Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts. 163
Macromolecular protein complex: a new way to understand the fibrinogen lowering effect of glycosaminoglycans? 163
Meal-generated oxidative stress in diabetes. The protective effect of red wine. 163
Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. 163
Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress 163
Increased glycosylated proteins in opiate addicts. 163
Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. 163
The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. 162
Glucose metabolism and hyperglycemia. 162
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. 162
Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. 161
Guideline for management of postmeal glucose. 161
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 161
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. 160
Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells. 160
How do we define cure of diabetes? 160
Detection of nitrotyrosine in the diabetic plasma: evidence for oxidative stress 160
Impaired insulin response to glucose but not to arginine in heroin addicts. 159
The combined insulin and sulfonylurea therapy in diabetes of elderly people. 159
Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. 159
Postprandial glucose regulation: new data and new implications. 159
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. 158
Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy? 158
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization. 158
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. 157
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene. 157
Atypical environmental factor in expressing type I (insulin-dependent) diabetes mellitus. 157
Non-enzymatic glycosylation reduces antithrombin III activity 157
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. 156
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial. 156
Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes. 156
Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. 156
Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. 156
Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes. 155
Point: postprandial glucose levels are a clinically important treatment target. 155
Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. 155
Evidence for a reduced heparin cofactor II biological activity in diabetes. 154
Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. 154
Angiotensin-receptor blockers, type 2 diabetes, and renoprotection. 154
Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. 154
Effects of S 21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients 154
Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Effects of short- and long-term simvastatin treatment 154
Impaired glucose metabolism in heroin and methadone users. 152
Antithrombin III and glycosylated hemoglobin in diabetic subjects 152
Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia 152
Tolrestat in the primary prevention of diabetic neuropathy. 152
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. 152
Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. 152
The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. 152
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. 152
Oxidative stress in diabetes. 151
Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. 151
Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. 151
Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. 150
High-fructose diet decreases catalase mRNA levels in rat tissues. 150
Effects of gliclazide beyond metabolic control. 149
The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. 149
Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. 149
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. 148
Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. 148
The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. 147
Effect of Atorvastatin and Irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress and inflammation in type 2 diabetic patients 147
Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. 147
Opiate addict as diabetic patient? 147
Fibrinogen plasma levels as a marker of thrombin activation in diabetes. 146
Totale 16.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.452 0 0 0 0 39 105 135 97 18 404 344 310
2022/20231.473 272 52 7 180 122 479 1 90 179 22 38 31
2023/2024324 51 30 9 5 53 47 3 10 83 14 3 16
2024/20254.209 46 292 49 81 50 159 227 192 415 603 640 1.455
2025/20266.828 333 764 710 983 859 521 718 258 390 683 378 231
2026/20272.637 140 420 625 1.318 134 0 0 0 0 0 0 0
Totale 36.162